<SEC-DOCUMENT>0001193125-16-657331.txt : 20160726
<SEC-HEADER>0001193125-16-657331.hdr.sgml : 20160726
<ACCEPTANCE-DATETIME>20160726080532
ACCESSION NUMBER:		0001193125-16-657331
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160726
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160726
DATE AS OF CHANGE:		20160726

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANOVO HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001497253
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				271488943
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35996
		FILM NUMBER:		161783219

	BUSINESS ADDRESS:	
		STREET 1:		6275 NANCY RIDGE DRIVE
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-9994

	MAIL ADDRESS:	
		STREET 1:		6275 NANCY RIDGE DRIVE
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REAL ESTATE RESTORATION & RENTAL, INC.
		DATE OF NAME CHANGE:	20100722
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d232450d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of Earliest Event Reported): July&nbsp;26, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ORGANOVO HOLDINGS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission
File Number: 001-35996 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>27-1488943</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6275 Nancy Ridge Drive, Suite 110 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>San Diego, CA 92121 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices, including zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(858) 224-1000 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of
Listing. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;26, 2016, Organovo Holdings, Inc. (the &#147;Company&#148;) provided written notice to the NYSE MKT (&#147;NYSE MKT&#148;) of
its intention to voluntarily delist its common stock, $0.001 par value per share (&#147;Common Stock&#148;), on the NYSE MKT and to list its Common Stock on the Nasdaq Global Market of The Nasdaq Stock Market LLC (&#147;Nasdaq&#148;). The Company
expects the listing and trading of its Common Stock on the NYSE MKT will cease at market close on August&nbsp;5, 2016, and that trading of its Common Stock will commence on Nasdaq on August&nbsp;8, 2016. The Common Stock has been approved for
listing on Nasdaq, with the Common Stock continuing to trade under the symbol &#147;ONVO.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release issued by the Company
announcing the transfer to Nasdaq is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01 Financial Statements and
Exhibits </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release, dated July 26, 2016.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>ORGANOVO HOLDINGS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: July&nbsp;26, 2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Keith Murphy</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Keith Murphy</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and President</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit Index </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release, dated July 26, 2016.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d232450dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g232450snap1.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Investor Contact:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Press Contact:</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steve Kunszabo</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Organovo Holdings, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 (858) 224-1092</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>skunszabo@organovo.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jessica Yingling</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Little Dog Communications</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 (858) 480-2411</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>jessica@litldog.com</U></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORGANOVO TO BEGIN TRADING ON NASDAQ STOCK MARKET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SAN DIEGO &#150; July&nbsp;26, 2016 &#150; Organovo Holdings, Inc. (NYSE MKT:ONVO) (&#147;Organovo&#148;), a three-dimensional biology company focused on
delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that it will move its stock exchange listing to the NASDAQ Stock Market from the NYSE MKT. The Company expects its common stock will begin trading
on the NASDAQ Global Market on August&nbsp;8, 2016, and its shares will continue to trade under the &#147;ONVO&#148; ticker symbol. Organovo&#146;s common stock will continue to trade on the NYSE MKT until the market close on August&nbsp;5, 2016.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;NASDAQ is home to many of the world&#146;s most innovative biotechnology and healthcare companies and is a natural fit for Organovo,&#148; said
Keith Murphy, CEO, Organovo. &#147;We believe that this move will work to the long-term benefit of our shareholders.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Organovo Holdings,
Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Organovo&nbsp;designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications.&nbsp;The
Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners. Organovo&#146;s&nbsp;3D human tissues have the potential to accelerate the drug discovery process, enabling
treatments to be developed faster and at lower cost.&nbsp;The Company&#146;s initial product is the exVive3D<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>&nbsp;Human Liver Tissue for use in toxicology and other preclinical drug
testing.&nbsp;Additional products are in development, with the anticipated release of the exVive3D&nbsp;Human </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Kidney Tissue scheduled for the third quarter of calendar year 2016.&nbsp;The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical
applications.&nbsp;In addition to numerous scientific publications, the Company&#146;s technology has been featured in&nbsp;The Wall Street Journal,&nbsp;Time Magazine, The Economist, Forbes, and numerous other media outlets. Organovo&nbsp;is
changing the shape of life science research and transforming medical care. Learn more at&nbsp;<U>www.organovo.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Any statements contained in this press release that do not describe historical facts constitute forward-looking statements as that term is defined
in the Private Securities Litigation Reform Act of 1995.&nbsp;Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties.&nbsp;The factors that could cause the
Company&#146;s actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company&#146;s ability to develop, market and sell products and services based on its
technology; the expected benefits and efficacy of the Company&#146;s products, services and technology; the market acceptance of the Company&#146;s products and services; the Company&#146;s business, research, product development, regulatory
approval, marketing and distribution plans and strategies; the Company&#146;s ability to successfully complete the contracts and recognize revenue from its existing collaborative relationships; the Company&#146;s ability to secure additional
collaborative relationships; and the Company&#146;s ability to move its stock exchange listing to the NASDAQ Global Market from the NYSE MKT.&nbsp;These and other factors are identified and described in more detail in the Company&#146;s filings with
the&nbsp;SEC, including its Annual Report on Form 10-K filed with the&nbsp;SEC&nbsp;on&nbsp;June 9, 2016. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made.&nbsp;These
cautionary statements should be considered with any written or oral forward-looking statements that the Company may issue in the future.&nbsp;Except as required by applicable law, including the securities laws of&nbsp;the&nbsp;United States, the
Company does not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>### </I></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g232450snap1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g232450snap1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?B<4G?H!#+=Q0<22(C=@[ 52BV@!9_,4M$\;CL5.0*EJ2
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M53BKE'&WEQ<?"?XGZA+%&3;S(S1)V;=T_*NFDHXB-I"V-[X.^'Y=2EUOQ1=
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M;W TO+<#A@#V]*EL"3!R.<8[5(!C'2FP#:<\8%&H"!6"XW$^YHU <!BD M,
JH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
